Use of Systemic Bioregulatory Medicine in an Alopecic Canine Patient Associated with Metronomic Chemotherapy for the Management of Hepatoid Cell Carcinoma: Case Report

A 12-year-old male canine diagnosed with hepatoid cell carcinoma underwent metronomic chemotherapy, resulting in gastroenteric issues, generalized alopecia, and vision loss. Conventional therapy over four months showed no improvement, leading to a suggestion of euthanasia. However, after one month of bioregulatory medicine therapy, the dog exhibited significant health improvements, including recovery from gastroenteropathy, generalized folliculogenesis, and restored vision. The dog achieved full health without needing further medication and did not experience perianal lesion recurrence during bioregulatory therapy. This case highlighted that conventional chemotherapy is not the only therapeutic option, as bioregulatory medicine not only addressed chemotherapy side effects but also enhanced the animal's survival and well-being, offering a favorable prognosis.